Latest News

Tuesday, August 04, 2015 | Management/Leadership, Calhoun Vision

Calhoun Vision Elects Former SEC Chairman and Congressional Leader Chris Cox to Board of Directors

Calhoun Vision announced that prominent public service leader and former chairman of the SEC, Chris Cox, has joined the company's board of directors, according to a company news release. Mr. Cox i…

Read the full story

Tuesday, August 04, 2015 | Acquisitions/Mergers, Shire

Shire Makes Unsolicited Bid to Buy Baxalta for $30 Billion

Shire made an unsolicited offer to buy Baxalta, a business spun off by Baxter International Inc. last month, for about $30 billion in stock to create a biotech company focused on rare diseases. Shire …

Read the full story

Tuesday, August 04, 2015 | Management/Leadership, Rapid Pathogen Screening

RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs

RPS Diagnostics announced that Robert A. Gregg, PhD, has joined RPS as senior vice president of Clinical and Regulatory Affairs. Dr. Gregg has more than 30 years of relevant experience and achie…

Read the full story

Tuesday, August 04, 2015 | Glaucoma

A Quicker Way to Diagnose Glaucoma

A team of researchers from IISc have developed a Java-based software that can detect the condition using images of the interior surface of the eye

Read the full story

Tuesday, August 04, 2015 | Medical Studies

Ocular Alkali Burns: Treatment Algorithm Improves Care

A treatment algorithm for managing patients who presented to an emergency department with mild ocular alkali burns led to standardized care and better outcomes in a small, single-center, retrospective…

Read the full story

Monday, August 03, 2015 | Miscellaneous, Heidelberg Engineering

Heidelberg Engineering to Relocate US Headquarters to the East Coast

Heidelberg Engineering is relocating its US headquarters from Carlsbad, California to Franklin, Massachusetts, according to a company news release. The new location on the east coast will inte…

Read the full story

Monday, August 03, 2015 | FDA Approval/Clearance, Bausch+Lomb

Bausch + Lomb's Victus Femtosecond Laser Platform Receives 510(k) Clearance from FDA for Enhanced Patient Interface Kit

Bausch + Lomb announced today its Victus Femtosecond Laser Platform has received 510(k) clearance from the FDA for an enhanced patient interface kit, according to a company news release. The interface…

Read the full story

Monday, August 03, 2015 | Medical Studies

Human Lacrimal Glands Visualized With OCT

Human lacrimal glands can be successfully imaged using optical coherence tomography (OCT), a new study shows. The images did not provide a way to distinguish healthy eyes from those with dry eye syndr…

Read the full story

Monday, August 03, 2015 | Acquisitions/Mergers, Shire

Shire Acquires Foresight Biotherapeutics for $300 Million

Shire announced that it has acquired New York-based, privately held Foresight Biotherapeutics for $300 million. With the acquisition, Shire acquires the global rights to FST-100 (topical ophthalmic dr…

Read the full story

Monday, August 03, 2015 | Medical Studies

Patients With Psoriasis Should be Examined for Uveitis

A newly identified bidirectional association between psoriatic disease and uveitis has led researchers to suggest that patients with psoriasis and psoriatic arthritis should be closely evaluated for e…

Read the full story

Friday, July 31, 2015 | Medical Studies

Human Lacrimal Glands Visualized With OCT

Human lacrimal glands can be successfully imaged using optical coherence tomography (OCT), a new study shows. The images did not provide a way to distinguish healthy eyes from those with dry eye syndr…

Read the full story

Friday, July 31, 2015 | Glaucoma, Product Releases, Glaukos Corporation

Glaukos Receives Regulatory Approval in Australia for iStent Inject

Glaukos announced regulatory approval from the Australian Therapeutic Goods Administration (TGA) for its iStent inject Trabecular Micro-Bypass Stent, according to a company news release. With TGA appr…

Read the full story

Friday, July 31, 2015 | Medical Studies

Patients With Psoriasis Should be Examined for Uveitis

A newly identified bidirectional association between psoriatic disease and uveitis has led researchers to suggest that patients with psoriasis and psoriatic arthritis should be closely evaluated for e…

Read the full story

Friday, July 31, 2015 | Management/Leadership

Alcon Announces Leadership Change for North American Region

Alcon has appointed Sergio Duplan as region president, Alcon North America. He succeeds Robert Warner, who assumes a new Alcon executive committee role as global franchise head, Alcon Vision Care, acc…

Read the full story

Thursday, July 30, 2015 | Acquisitions/Mergers

Brazos Private Equity Partners To Sell Vision Source To Essilor

Brazos Private Equity Partners, a Dallas-based private investment firm, announced that it has agreed to sell its portfolio company, Vision Source, to Essilor of America, a subsidiary of Paris-based Es…

Read the full story
Load More
 Stock Price  Change 
 Actavis $298.98  0.00% 
 Aerie Pharmaceuticals, Inc. $18.01  -0.72% 
 Akorn, Inc. $45.86  -0.65% 
 Alimera Sciences, Inc. $4.70  -1.47% 
 Avalanche Biotechnologies $15.13  -1.69% 
 Bayer $148.13  0.00% 
 Can-Fite Biopharma $1.96  2.41% 
 Carl Zeiss Meditec $25.90  -1.16% 
 Cooper Companies, Inc. $177.16  0.01% 
 Eleven Biotherapeutics $2.70  -0.55% 
 Escalon Medical Corp. $1.48  6.47% 
 Essilor International $128.25  0.00% 
 Imprimis Pharmaceuticals, Inc. $7.76  -1.02% 
 InSite Vision, Inc. $0.18  0.00% 
 IRIDEX Corporation $6.95  -0.71% 
 Johnson & Johnson $100.14  0.12% 
 Luxottica Group, S.p.A. $72.74  0.08% 
 Merck & Company, Inc. $58.71  -0.58% 
 NicOx $1.83  0.44% 
 NovaBay Pharmaceuticals, Inc. $0.59  0.54% 
 Novartis AG Common Stock $103.83  -0.51% 
 Ocular Therapeutix $22.26  0.95% 
 Ophthotech Corporation $69.85  -0.70% 
 QLT $3.80  0.53% 
 Quantel $2.99  -1.97% 
 Regeneron $583.50  5.27% 
 Roche $36.01  0.17% 
 Second Sight Medical Products $14.19  0.78% 
 STAAR Surgical Company $8.08  -1.34% 
 TearLab Corporation $2.55  -8.60% 
 Thrombogenics $5.39  0.00% 
 Topcon Corporation $18.45  0.00% 
 Valeant Pharmaceuticals $260.00  1.08% 
 Xoma $0.78  0.89%